title: A Pilot Comparative Study of the Clarity and Assessability of the Drug Management Standards of Accreditation Canada and the US Joint Commission.
abstract: BACKGROUND
  There are few data comparing the drug management standards of the US and Canadian agencies that accredit health care institutions.
  
  
  OBJECTIVE
  To evaluate the clarity and assessability of criteria in the drug management standards adopted by Accreditation Canada and the Joint Commission (United States).
  
  
  METHODS
  A pilot study was conducted to compare the clarity and assessability of the criteria listed in the 2 standards. Criteria that were common to the 2008 versions of the Canadian and US drug management standards were identified. A panel of 12 health care professionals was assembled to independently rate the clarity (i.e., clear or unclear) and the assessability (i.e., assessable or not assessable) of each statement, using a validated comparative grid.
  
  
  RESULTS
  In total, there were 143 Canadian standards and 103 US standards. Sixty-two (43%) of the 143 Canadian criteria could be directly paired with a US criterion, whereas 70 (68%) of the 103 US criteria could be paired with one or more Canadian criteria. Six of the US criteria were paired with more than one Canadian criterion, and 12 of the Canadian criteria could be paired with more than one US criterion. Four of the 22 themes in the Canadian standards had no equivalent criteria in the US standards. Panel members from the pharmaceutical practice group evaluated the clarity and assessability of the Canadian criteria more severely than panel members from the nursing practice group: 86% versus 95% of individual ratings were deemed "clear" by these two groups, respectively (p < 0.001) and 64% versus 88% of individual ratings were deemed "assessable" (p < 0.001). There were no criteria that were considered unclear or unassessable by all of the panel members.
  
  
  CONCLUSIONS
  Few data are available on drug management standards and their impact on health care. A better understanding of these standards, as well as comparisons of Canadian standards with those of other countries, might help in determining their clarity and assessability. A larger-scale study is required to validate the observations reported here.
authors.affiliation: is a pharmacy resident with the Université de Toulouse III, Paul Sabatier, Toulouse, France. She is also a Research Assistant with the Research Unit in Pharmacy Practice, CHU Sainte-Justine, Montréal, Quebec.
authors.forename: Jordane
authors.initials: J
authors.lastname: Alemanni
authors.forename: Lionel
authors.initials: L
authors.lastname: Brisseau
authors.forename: Denis
authors.initials: D
authors.lastname: Lebel
authors.forename: Régis
authors.initials: R
authors.lastname: Vaillancourt
authors.forename: Louis
authors.initials: L
authors.lastname: Rocheleau
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Bussières